Osaka, Japan

Kouki Fuchino

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kouki Fuchino: Innovator in Pharmaceutical Compounds

Introduction

Kouki Fuchino is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for pain management. With a total of seven patents to his name, Fuchino's work has the potential to impact medical treatments significantly.

Latest Patents

Fuchino's latest patents include innovative compounds such as Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds. This invention relates to compositions that comprise an effective amount of these compounds and methods to treat or prevent conditions like pain. Another notable patent is for 9'-Aza[3,9′-bi(bicyclo[3.3.1]nonan)]-3′-one and its preparation. This patent discloses compounds of specific formulas and their utility in manufacturing processes for obtaining these compounds, which also aim to treat or prevent pain.

Career Highlights

Throughout his career, Kouki Fuchino has worked with reputable companies in the pharmaceutical industry. Notable among these are Purdue Pharma L.P. and Shionogi & Company Limited. His work in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and therapeutic applications.

Collaborations

Fuchino has collaborated with several professionals in his field, including Naoki Tsuno and Jiangchao Yao. These collaborations have likely contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Kouki Fuchino stands out as a significant figure in pharmaceutical innovation, with a focus on compounds that address pain management. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…